NGM Biopharmaceuticals In... (NGM)

AI Score

Unlock

1.54

-0.02 (-1.28%)

At close: Apr 03, 2024, 3:59 PM

NGM Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q2 2018	Q4 2017
Period Ending	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017
Cash & Equivalents	58.81M	51.48M	53.27M	67.55M	73.46M	101.45M	63.38M	109.87M	151.79M	145.83M	99.4M	148.11M	147.02M	253.98M	249.32M	256.95M	245.6M	303.02M	265.07M	47.31M	56.92M	38.91M	25.59M
Short-Term Investments	88.37M	114.57M	140.27M	163.46M	198.04M	198.7M	234.43M	219.96M	214.46M	237.6M	291.15M	264.54M	148.14M	33.97M	62.78M	71.52M	98.91M	53.56M	97.12M	146.13M	149.71M	150.31M	148.09M
Long-Term Investments	2.46M	2.46M	2.46M	2.46M	3.95M	3.95M	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.94M	45.15M
Other Long-Term Assets	2.94M	4.84M	4.86M	4.3M	4M	5.3M	5.47M	9.14M	8.99M	8.52M	7.09M	5.96M	6.09M	8.07M	7.34M	4.12M	5.68M	5.81M	6.19M	9.16M	7.63M	3.41M	3.38M
Receivables	58K	n/a	736K	1.26M	7.58M	4.38M	6.67M	103K	4.95M	4.4M	3.59M	4.92M	6.43M	7.21M	3.08M	742K	5.21M	n/a	881K	n/a	3.67M	n/a	n/a
Inventory	n/a	n/a	1.5M	1.5M	1.00	1.00	n/a	n/a	-4.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	9.2M	7.99M	8.62M	8.77M	9.79M	11.17M	14.36M	7.69M	8.08M	8.05M	8.99M	8.27M	6.84M	7.08M	7.45M	9.1M	5.53M	7.75M	5.28M	5.71M	4.25M	2.25M	1.85M
Total Current Assets	156.44M	177.04M	204.4M	242.53M	288.86M	315.7M	318.84M	337.62M	379.28M	395.88M	403.13M	425.85M	308.43M	302.24M	322.62M	338.31M	355.25M	364.32M	368.34M	199.15M	214.56M	191.48M	175.53M
Property-Plant & Equipment	7.03M	7.82M	8.83M	9.55M	10.59M	10.92M	11.57M	13.01M	14.12M	11.45M	12.79M	13.73M	14.53M	15.77M	17.32M	18.27M	19.48M	20.48M	22.17M	23.32M	23.89M	26.73M	24.87M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.42M	15.11M	16.14M	16.31M	18.54M	20.17M	18.53M	22.15M	23.11M	19.98M	19.88M	19.69M	20.62M	23.84M	24.66M	22.39M	25.16M	26.3M	28.36M	32.48M	31.53M	46.09M	73.41M
Total Assets	168.87M	192.15M	220.54M	258.84M	307.4M	335.87M	337.37M	359.77M	402.39M	415.86M	423.01M	445.54M	329.04M	326.08M	347.28M	360.7M	380.4M	390.62M	396.7M	231.63M	246.09M	237.56M	248.94M
Account Payables	2.98M	4.69M	5.86M	13.29M	8.45M	3.56M	6.87M	4.82M	5.25M	7.63M	5.14M	7.54M	9.66M	1.61M	1.93M	3.65M	9.03M	4.46M	3.16M	4.2M	5.78M	4.2M	1.89M
Deferred Revenue	n/a	107K	689K	376K	366K	6.97M	6.5M	5.12M	17.77M	12.29M	4.96M	n/a	n/a	4.59M	2.07M	n/a	4.87M	14.62M	17.44M	22.04M	19.02M	20.82M	21.36M
Short-Term Debt	n/a	1.38M	2.75M	4.07M	5.38M	5.31M	5.23M	5.15M	5.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	17.1M	16.17M	19.13M	20.16M	33.64M	32.76M	23.94M	29.48M	33.26M	37.81M	34.94M	32.77M	32.92M	31.52M	29.69M	24.81M	25.82M	21.4M	18.05M	16.64M	16.69M	13.88M	13.64M
Total Current Liabilities	20.08M	22.34M	28.42M	37.9M	47.84M	48.6M	42.54M	44.56M	61.35M	57.73M	45.04M	40.31M	42.58M	37.72M	33.7M	28.46M	39.72M	40.48M	38.65M	42.88M	41.49M	38.9M	36.89M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	1.38M	2.75M	4.07M	5.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	149K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.09M	4.89M	5.66M	6.42M	11.66M	12.42M	13.27M	9.97M	10.95M	11.92M	307.93M	13.78M	308.77M	310.28M
Total Long-Term Liabilities	149K	n/a	n/a	17.37M	14.2M	1.38M	2.75M	4.07M	5.38M	4.09M	4.89M	5.66M	6.42M	11.66M	12.42M	13.27M	9.97M	10.95M	11.92M	307.93M	17.72M	322.11M	333.03M
Total Liabilities	20.23M	22.34M	28.42M	37.9M	47.84M	49.98M	45.29M	48.64M	66.74M	61.82M	49.94M	45.96M	49M	49.38M	46.12M	41.73M	49.68M	51.43M	50.57M	350.81M	59.21M	361.01M	369.92M
Total Debt	n/a	1.38M	2.75M	4.07M	5.38M	6.69M	7.98M	9.23M	10.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	83K	83K	83K	82K	82K	82K	79K	78K	78K	78K	77K	77K	71K	69K	69K	68K	67K	66K	66K	7K	54K	13K	12K
Retained Earnings	-724.01M	-696.34M	-667.54M	-629.28M	-581.63M	-545.2M	-497.94M	-451.42M	-418.97M	-391.73M	-362.87M	-326.18M	-298.63M	-270.64M	-240.88M	-215.26M	-196.14M	-180.2M	-169.29M	-161.62M	-147.19M	-153.84M	-146.7M
Comprehensive Income	18K	-78K	-149K	-97K	-302K	-915K	-1.08M	-677K	-129K	-11K	5K	-18K	4K	15K	137K	-55K	25K	99K	102K	-45K	-267K	-498K	-431K
Shareholders Equity	148.64M	169.81M	192.12M	220.93M	259.56M	285.89M	292.08M	311.14M	335.65M	354.04M	373.07M	399.58M	280.04M	276.7M	301.16M	318.97M	330.72M	339.19M	346.13M	-119.18M	186.88M	-123.45M	-120.98M
Total Investments	90.82M	114.57M	140.27M	163.46M	198.04M	198.7M	234.43M	219.96M	214.46M	237.6M	291.15M	264.54M	148.14M	33.97M	62.78M	71.52M	98.91M	53.56M	97.12M	146.13M	149.71M	166.26M	193.24M